Infectious Diseases & Vaccinology
March 21, 2022
COVID-19: A Coronavirus Spring?
COVID-19 infections rebound in the West, while China faces its biggest outbreak since 2019. Amid these worries, pharma continues innovation.
Infectious Diseases & Vaccinology
Infectious Diseases & Vaccinology
March 9, 2022
Pharmacovigilance and Lessons from the Pandemic
The pandemic has forced a revision of pharmacovigilance, its role in industry and society. We examine lessons learned for the future.
Infectious Diseases & Vaccinology
March 7, 2022
COVID-19 Research Continues Unabated
In a bid to pre-empt novel variants, the search for COVID-19 treatments and vaccines continues unabated – with over 100 trials on-going.
Infectious Diseases & Vaccinology
March 2, 2022
Diversity in Clinical Trials After COVID
We explore the impact of COVID-19 on clinical trials, their design and organization – with a particular focus on diversity and how that can be improved.
Infectious Diseases & Vaccinology
February 14, 2022
Troubled Hearts: The Chronic Consequences of COVID-19 Infection
COVID-19 leaves long-lasting effects behind after acute disease – many of these include significant cardiovascular disease risks.
Infectious Diseases & Vaccinology
February 9, 2022
COVID-19 and the Possibility of Neuropathogenesis
We explore the possible neuropathogenesis arising from acute and chronic COVID-19 disease – and the research currently investigating the field.
Infectious Diseases & Vaccinology
January 24, 2022
Moving on from Omicron
A weekly update on new research on COVID and the evolving policy situation in response to Omicron.
Infectious Diseases & Vaccinology
January 17, 2022
Omicron After the Peak
Omicron shows strong signs of abating in areas affected early in the wave. New research and understandings promise better responses in the future.
Infectious Diseases & Vaccinology
January 12, 2022
The Future of Antibiotics
Examining the growing concerns of antibiotic resistance, and the lack of development and monetization issues in discovering novel antibiotics.
Infectious Diseases & Vaccinology
January 10, 2022
Living with Omicron: Insights in the New Year
As the Omicron waves unfold throughout the globe, we find new lessons in policy and disease control, and pharmaceutical innovations.
Infectious Diseases & Vaccinology
December 20, 2021
New Understandings: Omicron before the New Year
A brief summary of understandings gleaned regarding the Omicron variant for the week leading up to 20 Dec 2021.
Infectious Diseases & Vaccinology
December 13, 2021
Omicron Continues Unabated
The Omicron variant of SARS-CoV-2 continues to spread throughout the developed and developing world alike, as questions remain over vaccines.
Infectious Diseases & Vaccinology
December 6, 2021
The Story So Far: SARS-CoV-2 Omicron
An update on the Omicron Variant of Concern of SARS-CoV-2 and the societal and industrial action needed to anticipate the evolution of COVID-19
Infectious Diseases & Vaccinology
November 29, 2021
The Evolution of COVID & New Variants
A brief summary of the factors affecting the evolution of SARS-CoV-2 and the medical and societal conditions that enable it.
Infectious Diseases & Vaccinology
November 23, 2021
DCTs and the Effects of the Pandemic on Clinical Trial Operations
A review of the effects of the pandemic on clinical trial operations, and the rise of decentralised clinical trials as a consequence
Infectious Diseases & Vaccinology
November 16, 2021
COVID-19 Inspires Innovation in Vaccination Developments
Recent advancements in vaccine development inspired by COVID-19 vaccines
Infectious Diseases & Vaccinology
November 15, 2021
Antiviral Therapies: The Story So Far
COVID has renewed interest in antiviral therapy as a treatment option; we explore a brief overview of antiviral therapy so far.
Infectious Diseases & Vaccinology
September 20, 2021
Making Progress: Cancer Vaccines – Where Are We Now?
Some of the latest advancements show innovative approaches to cancer vaccines, including the mRNA research used to create COVID-19 vaccines.
Infectious Diseases & Vaccinology
September 6, 2021
The Latest Advancements of COVID-19 Treatment
Thanks to research like the Solidarity Trial, a number of COVID-19 therapies are in development for hospitalised patients with severe illness.
